AffiliationCork Cancer Research Centre, Mercy University Hospital and Leslie C. Quick Jnr., Laboratory, University College Cork, Cork, Ireland.
MeSHCTLA-4 Antigen/antagonists & inhibitors
Forkhead Transcription Factors/antagonists & inhibitors
MetadataShow full item record
CitationCancer Res. 2011 Nov 15;71(22):6915-20. Epub 2011 Nov 8.
AbstractInfiltration of tumors by regulatory T cells confers growth and metastatic advantages by inhibiting antitumor immunity and by production of receptor activator of NF-kappaB (RANK) ligand, which may directly stimulate metastatic propagation of RANK-expressing cancer cells. Modulation of regulatory T cells can enhance the efficacy of cancer immunotherapy. Strategies include depletion, interference with function, inhibition of tumoral migration, and exploitation of T-cell plasticity. Problems with these strategies include a lack of specificity, resulting in depletion of antitumor effector T cells or global interruption of regulatory T cells, which may predispose to autoimmune diseases. Emerging technologies, such as RNA interference and tetramer-based targeting, may have the potential to improve selectivity and efficacy.
- Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy.
- Authors: Liu Y, Zheng P
- Issue date: 2020 Jan
- Targeting regulatory T cells.
- Authors: Ménétrier-Caux C, Curiel T, Faget J, Manuel M, Caux C, Zou W
- Issue date: 2012 Mar
- Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity.
- Authors: Nawaf MG, Ulvmar MH, Withers DR, McConnell FM, Gaspal FM, Webb GJ, Jones ND, Yagita H, Allison JP, Lane PJL
- Issue date: 2017 Aug 1
- CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy.
- Authors: Brunner-Weinzierl MC, Rudd CE
- Issue date: 2018
- Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy.
- Authors: Dees S, Ganesan R, Singh S, Grewal IS
- Issue date: 2021 Feb